Published online before print November 22, 2004, doi: 10.1161/01.CIR.0000149713.48317.27
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2004;110:3488-3492.)
© 2004 American Heart Association, Inc.
Preventive Cardiology |
Childhood Adiposity as a Predictor of Cardiac Mass in Adulthood
The Bogalusa Heart Study
From the Tulane Center for Cardiovascular Health, Tulane University Health Sciences Center, New Orleans, La.
Correspondence to Gerald S. Berenson, MD, Tulane Center for Cardiovascular Health, 1440 Canal St, Room 1829, New Orleans, LA 70112. E-mail berenson{at}tulane.edu
Received July 1, 2004; revision received September 3, 2004; accepted September 9, 2004.
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Background— The association between left ventricular hypertrophy, an independent predictor of cardiovascular (CV) morbidity and mortality, and CV risk factors has been well documented in childhood and in adulthood. However, information on the relationship between left ventricular mass (LVM) in adults and longitudinal measurements of CV risk factors from childhood to adulthood is limited.
Methods and Results— LVM was obtained with 2D M-mode echocardiography in a community-based sample of 467 young adults (71% white and 29% black) aged 20 to 38 years who were examined an average of 6 times for CV risk factors from childhood to adulthood. The average follow-up period was 21.5 years. The cumulative burden of each risk factor was calculated as the area under the curve for each individual. Compared with whites, blacks had greater LVM (indexed to height2.7; P<0.05). In multiple regression analyses, adiposity (measured as body mass index) in childhood, adiposity and systolic blood pressure in adulthood, and the cumulative burden of adiposity and systolic blood pressure from childhood to adulthood were significant predictors of LVM index in young adults.
Conclusions— These observations, by showing that adiposity beginning in childhood is a consistent predictor of LVM in young adults, underscore the importance of obesity in the development of left ventricular hypertrophy and the need for early prevention.
Key Words: ventricles • adiposity • blood pressure
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
It is now well known that cardiovascular (CV) risk factors are identifiable in childhood and are predictive of adult CV risk.1–4 Longitudinal epidemiological studies have shown the utility of different traditional risk factors measured from childhood to adulthood in predicting subclinical CV changes in adults.5–9 Among the subclinical measures, left ventricular mass (LVM) assessed by 2D M-mode echocardiography is recognized as an important and powerful predictor of CV morbidity and mortality, independent of other traditional risk factors.10–12
The association between LVM and CV risk factors has been well documented in childhood and in adulthood.13–18 Previously, we have shown that increased adiposity and blood pressure are the 2 major factors that lead to excessive cardiac growth beyond that of normal growth in children.15 Similar findings were also observed in adults.17 However, information linking childhood CV risk factor variables and their cumulative burden since childhood to LVM in young adults is lacking. Such information is vitally important for CV risk assessment beginning in youth. Longitudinal data from the Bogalusa Heart Study, a biracial (black-white) community-based investigation of the natural history of CV disease beginning in childhood,2,3,19 provide a unique opportunity to examine the influence of traditional CV risk factors measured from childhood to adulthood on LVM measured in young adults.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Study Population
Between 1973 and 1996, 7 cross-sectional surveys of children aged 4 to 17 years and 5 surveys of young adults aged 18 to 38 years who participated as children were conducted in the biracial (65% white, 35% black) community of Bogalusa, La. This panel design, which was based on repeated cross-sectional examinations conducted approximately every 3 to 4 years, resulted in multiple observations during childhood and young adulthood and allowed an evaluation of the cumulative burden of risk factor variables beginning in childhood. During the last 6 months of the 1995 to 1996 survey of young adults (n=1420), M-mode echocardiography examination was performed on 467 subjects (71% white, 39% male) aged 20 to 38 years (average age 32.6 years) who were previously examined 2 to 12 times (average 6 times) since childhood. Compared with the rest of the study cohort, those who had echocardiography measurements had similar race, gender, and risk factor profiles (P=0.19 to 0.80), except that the latter group was 4 years older than the former (P<0.001). The average follow-up period was 21.5 years.
Written informed consent was obtained from parents or guardians in childhood and from the participants in adulthood. The Institutional Review Board of the Tulane University Health Sciences Center approved the protocol.
Examinations
All examinations followed essentially the same protocols. Subjects were instructed to fast for 12 hours before the screening, with compliance ascertained by interview on the morning of the examination. Height and weight were measured twice to within ±0.1 cm and ±0.1kg, respectively, and the average values were used to calculate body mass index (BMI; kg/m2) as a measure of overall adiposity.
Replicate blood pressure measurements were obtained on the right arm of the subjects in a relaxed, sitting position. Arm measurements, length and circumference, were made during the examination to ensure proper cuff size. Systolic and diastolic blood pressure levels were recorded as the first, fourth (in children), and fifth (in adults) Korotkoff phases with mercury sphygmomanometers. Blood pressure levels were reported as the mean of 6 replicate readings taken by each of 2 randomly assigned and trained observers.
Laboratory Analysis
During 1973 to 1986, cholesterol and triglycerides levels were measured by the use of chemical procedures with a Technicon AutoAnalyzer II (Technicon Instrument Corp) according to the laboratory manual of the Lipid Research Clinics Program.20 Since 1987, these variables were determined with the Abbott VP instrument (Abbott Laboratories) by enzymatic procedures.21,22 Both chemical and enzymatic procedures met the performance requirements of the Lipid Standardization Program of the Centers for Disease Control and Prevention (CDC), Atlanta, Ga, which routinely monitors the accuracy of measurements of total cholesterol, triglycerides, and HDL cholesterol concentrations. Measurements on CDC-assigned quality control samples showed no consistent bias over time within or between surveys. Serum lipoprotein cholesterols were analyzed with a combination of heparin-calcium precipitation and agar-agarose gel electrophoresis procedures.23
Left Ventricular Mass
LVM was assessed by 2D M-mode echocardiography with 2.25- and 3.5-MHz transducers according to the American Society of Echocardiography recommendations.24 Images were recorded on standard VHS videocassette tapes. All echocardiograms were digitized and measured on Tomtec/Freeland Cardiology Workstation digitizing systems (Tomtec/Freeland Systems). The coefficient of variation for interreader and intrareader variability for all measures of cardiac anatomy was <10%. LVM was calculated on the basis of the formula recommended by Devereux.25 The index of LVM to height2.7 (g/m2.7) was used to adjust for body size.
Statistical Methods
All data analyses were performed with SAS version 8.2. A general linear model was used to examine the race and gender differences of risk factor variables and LVM index, adjusted for covariates where appropriate. Whenever race-gender interaction was present, separate models were used by race or gender. The area under the curve (AUC) of serial measurements of each risk factor was used as a measure of cumulative risk burden from childhood to adulthood; its computation has been described previously in detail.8 Age was centered by subtracting 17.0, which was the average value of age in the total sample, to eliminate colinearity between the first- and second-order terms of age. Risk factors measured at the first and last examinations were used as childhood and adulthood values, respectively.
Pearson correlation coefficients were used to assess the relationships of LVM index to risk factors measured since childhood, with risk factors and LVM index standardized to race-, gender-, and age-specific z-scores; risk factor AUC values were standardized to race-, gender-, and average age-specific z-scores. LVM index and triglycerides were log-transformed before standardization. To explore the predictors of LVM index in young adults, multiple regression analysis was performed with LVM index as a dependent variable and risk factors measured since childhood as the independent variables, respectively, with all the variables standardized as described above.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Mean values of risk factor variables measured from childhood to adulthood and LVM index in adulthood in the study cohort are shown in Table 1, by race and gender. Blacks compared with whites showed higher levels of LVM index (P<0.05); this difference was more pronounced among females. With some exceptions in particular race, gender, and age groups, blacks had higher systolic blood pressure and HDL cholesterol and lower triglycerides than whites in general; males had higher systolic blood pressure, LDL cholesterol, and triglycerides and lower HDL cholesterol than females; and white males and black females had higher BMI than white females and black males, respectively.
|
Table 2 shows correlation coefficients between LVM index and risk factor variables measured from childhood to adulthood. The LVM index in young adults correlated significantly, although moderately, with BMI and systolic blood pressure measured in childhood, adulthood, or as the cumulative burden since childhood.
|
Table 3 shows results of multiple regression of LVM index on risk factor variables measured since childhood. Childhood BMI was the only independent predictor for adult LVM index. In adulthood, BMI and systolic blood pressure were independent correlates of LVM index. In terms of cumulative burden of risk factor variables since childhood, BMI and systolic blood pressure were independent predictors of LVM index. Thus, BMI was the most consistent predictor in all 3 models. A significant increasing trend in LVM index in young adults across BMI quartiles measured in childhood, adulthood, and as a cumulative burden since childhood further illustrates the consistency of this association (Figure).
|
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
The present study demonstrates that BMI measured in childhood and BMI and systolic blood pressure measured in adulthood and as cumulative burden since childhood are independent predictors of LVM in young adulthood. Of note, childhood adiposity and its persistence as indicated by the cumulative burden of BMI from childhood to adulthood were predictive of LVM in young adults. These observations from a community-based cohort free from the selection bias of a patient population indicate that childhood obesity plays an important role in the development of left ventricular hypertrophy in the general population.
Previous studies, including our own, have shown cross-sectional associations between LVM and BMI in children and adolescence.13–15,18,26 The contemporaneous BMI was also a major determinant of LVM index at the adult age in the present study, as has been shown previously.27–29 In the present study, those who had higher levels of childhood adiposity had larger cardiac size 21 years later, and the cumulative burden of adiposity since childhood increased the risk of cardiac enlargement.
Obesity affects the cardiac muscle through multiple mechanisms.30 Obesity alone can cause chronic volume overload and related greater cardiac output.31,32 Both hemodynamic and metabolic factors related to obesity can cause structure-function changes of the myocardium that result in increased LVM. Furthermore, hypertension associated with obesity increases the work of the heart and stimulates cardiac growth. Obesity-related oxidative stress, inflammation, and activation of the renin-angiotensin system can induce cardiac remodeling with increased cardiac myocyte and connective tissue matrix accumulation.33–35
The causality of the observed association between childhood adiposity and adulthood LVM cannot be established by this observational study. Persistence of adiposity over time plays a role in this regard. Among CV risk factors, childhood BMI was highly correlated with adulthood BMI over a 21-year period (r=0.54, P<0.001). Nevertheless, as mentioned previously, the association of obesity with LVM in childhood has been established cross-sectionally13,14 and, more importantly, longitudinally.15
In the present study, systolic blood pressure, either in adulthood or as a cumulative burden from childhood, was also an independent predictor of adult LVM index. Subjects with higher systolic blood pressure in childhood tended to have higher levels of LVM in adulthood, although the association was marginal (P=0.086) after adjustments for BMI and other covariates (Table 3). The adverse effect of elevated blood pressure to increase LVM is well documented, both cross-sectionally and longitudinally, in childhood and in adulthood.13–18,27,28 Taken together, these data, along with intervention studies,36,37 indicate that obesity and elevated blood pressure are the 2 major determinants acting in concert to develop increased cardiac mass.
The observed greater LVM in blacks than in whites has been documented in several studies15–18,26,28,38,39; however, the racial difference in LVM (Table 1) disappeared when further adjusted for BMI and systolic blood pressure (data not shown). Higher levels of blood pressure occur even in childhood in blacks, which can be detected with automatic instruments but are difficult to detect with indirect measurements by mercury sphygmomanometry.40 Additionally, the developing greater adiposity in blacks, especially black females, compared with whites partly accounts for this black-white difference in LVM. Also, blacks likely carry a greater blood pressure load over a day due to a smaller decline in nocturnal blood pressure.41,42
In conclusion, adiposity beginning in childhood plays an important role in the development of left ventricular hypertrophy. Furthermore, adiposity and systolic blood pressure may act in concert in this regard. Information from the present study, along with other accumulating evidence showing that childhood risk factors persist over time and are predictive of CV risk in adulthood, underscores the importance of childhood risk factors in the evolution of CV risk.5–9 Importantly, the reversibility of left ventricular hypertrophy by intervention36,37 indicates that early prevention and intervention will benefit those who are at increased CV risk beginning in childhood. With the continuing secular increases in overweight and obesity in epidemic proportion and parallel increases in blood pressure levels being noted in children,43,44 it becomes incumbent to begin prevention and intervention early in life to reduce or slow the progression of underlying changes occurring in the heart and vascular tree.45
|
Acknowledgments |
|---|
This study was supported by grants AG-16592 from the National Institute on Aging, HL-38844 from the National Heart, Lung, and Blood Institute, HD-043820 from the National Institute of Child Health and Human Development, and 0160261B from the American Heart Association. The Bogalusa Heart Study is a joint effort of many investigators and staff members whose contributions are gratefully acknowledged. We especially thank subjects for their long-term participation in this study.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Lauer RM, Shekelle RB, eds. Childhood Prevention of Atherosclerosis and Hypertension. New York, NY: Raven Press; 1980: 1–484.
2. Berenson GS, McMahan CA, Voors AW, Webber LS, Srinivasan SR, Frank GC, Foster TA, Blonde CV. Cardiovascular Risk Factors in Children: The Early Natural History of Atherosclerosis and Essential Hypertension. New York, NY: Oxford University Press; 1980: 1–413.
3. Berenson GS, ed. Causation of Cardiovascular Risk Factors in Children: Perspectives on Cardiovascular Risk in Early Life. New York, NY: Raven Press; 1986: 1–408.
4. Akerblom HK, Uhari M, Pesonen E, Dahl M, Kaprio EA, Nuutinen EM, Pietikainen M, Salo MK, Aromaa A, Kannas L, Keltikangas-Jarvinen L, Kuusela V, Rasanen L, Ronnemaa T, Knip M, Telama R, Valimaki I, Pyorala K, Viikari J. Cardiovascular risk in young Finns. Ann Med. 1991; 23: 35–39.[Medline] [Order article via Infotrieve]
5. Davis PH, Dawson JD, Riley WA, Lauer RM. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine Study. Circulation. 2001; 104: 2815–2819.
6. Berenson GS. Childhood risk factors predict adult risk associated with subclinical cardiovascular disease: the Bogalusa Heart Study. Am J Cardiol. 2002; 90 (suppl): 3L–7L.[CrossRef][Medline] [Order article via Infotrieve]
7. Raitakari OT, Juonala M, Kahonen M, Taittonen L, Laitinen T, Maki-Torkko N, Jarvisalo MJ, Uhari M, Jokinen E, Ronnemaa T, Akerblom HK, Viikari JS. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA. 2003; 290: 2277–2283.
8. Li S, Chen W, Srinivasan SR, Bond MG, Tang R, Urbina EM, Berenson GS. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. JAMA. 2003; 290: 2271–2276.
9. Li S, Chen W, Srinivasan SR, Berenson GS. Childhood blood pressure as a predictor of arterial stiffness in young adults: the Bogalusa Heart Study. Hypertension. 2004; 43: 541–546.
10. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990; 322: 1561–1566.[Abstract]
11. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Heart Study. Ann Intern Med. 1989; 110: 101–107.
12. Gardin JM, McClelland R, Kitzman D, Lima JA, Bommer W, Klopfenstein HS, Wong ND, Smith VE, Gottdiener J. M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study). Am J Cardiol. 2001 1; 87: 1051–1057.[CrossRef][Medline] [Order article via Infotrieve]
13. Burke GL, Arcilla RA, Culpepper WS, Webber LS, Chiang YK, Berenson GS. Blood pressure and echocardiographic measures in children: the Bogalusa Heart Study. Circulation. 1987; 75: 106–114.
14. Malcolm DD, Burns TL, Mahoney LT, Lauer RM. Factors affecting left ventricular mass in childhood: the Muscatine Study. Pediatrics. 1993; 92: 703–709.
15. Urbina EM, Gidding SS, Bao W, Pickoff AS, Berdusis K, Berenson GS. Effect of body size, ponderosity, and blood pressure on left ventricular growth in children and young adults in the Bogalusa Heart Study. Circulation. 1995; 91: 2400–2406.
16. Gardin JM, Wagenknecht LE, Anton-Culver H, Flack J, Gidding S, Kurosaki T, Wong ND, Manolio TA. Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women: the CARDIA Study. Circulation. 1995; 92: 380–387.
17. Gardin JM, Brunner D, Schreiner PJ, Xie X, Reid CL, Ruth K, Bild DE, Gidding SS. Demographics and correlates of five-year change in echocardiographic left ventricular mass in young black and white adult men and women: the Coronary Artery Risk Development in Young Adults (CARDIA) study. J Am Coll Cardiol. 2002; 40: 529–535.
18. Dekkers C, Treiber FA, Kapuku G, Van Den Oord EJ, Snieder H. Growth of left ventricular mass in African American and European American youth. Hypertension. 2002; 39: 943–951.
19. The Bogalusa Heart Study 20th Anniversary Symposium. Am J Med Sci. 1995; 310 (suppl 1): S1–S138.[Medline] [Order article via Infotrieve]
20. Lipid Research Clinics Program. Manual of Laboratory Operations, I: Lipid and Lipoprotein Analysis. DHEW publication No. (NIH) 75-628. Washington, DC: National Institutes of Health; 1974.
21. Allain CC, Poon LS, Chan CSG. Enzymatic determination of total serum cholesterol. Clin Chem. 1974; 20: 470–475.[Abstract]
22. Buculo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973; 19: 476–482.[Abstract]
23. Srinivasan SR, Berenson GS. Serum lipoproteins in children and methods for study. In: Lewis LA, ed. CRC Handbook of Electrophoresis, v. III: Lipoprotein Methodology and Human Studies. Boca Raton, Fla: CRC Press; 1983: 185–204.
24. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978; 58: 1072–1083.
25. Devereux RB. Detection of left ventricular hypertrophy by M-mode echocardiography: anatomic validation, standardization, and comparison to other methods. Hypertension. 1987; 9 (pt 2): II-19–II-26.[Medline] [Order article via Infotrieve]
26. Hanevold C, Waller J, Daniels S, Portman R, Sorof J, International Pediatric Hypertension Association. The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association. Pediatrics. 2004; 113: 328–333.
27. Fox E, Taylor H, Andrew M, Han H, Mohamed E, Garrison R, Skelton T. Body mass index and blood pressure influences on left ventricular mass and geometry in African Americans: The Atherosclerotic Risk In Communities (ARIC) Study. Hypertension. 2004; 44: 55–60.
28. Lorber R, Gidding SS, Daviglus ML, Colangelo LA, Liu K, Gardin JM. Influence of systolic blood pressure and body mass index on left ventricular structure in healthy African-American and white young adults: the CARDIA study. J Am Coll Cardiol. 2003; 41: 955–960.
29. Lauer MS, Anderson KM, Kannel WB, Levy D. The impact of obesity on left ventricular mass and geometry: the Framingham Heart Study. JAMA. 1991; 266: 231–236.
30. Schunkert H. Obesity and target organ damage: the heart. Int J Obes Relat Metab Disord. 2002; 26 (suppl 4): S15–S20.[CrossRef]
31. Alexander JK. The cardiomyopathy of obesity. Prog Cardiovasc Dis. 1985; 27: 325–334.[Medline] [Order article via Infotrieve]
32. Lorell BH, Carabello BA. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation. 2000; 102: 470–479.
33. Sabri A, Hughie HH, Lucchesi PA. Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes. Antiox Redox Signal. 2003; 5: 731–740.[CrossRef][Medline] [Order article via Infotrieve]
34. Sorescu D, Griendling KK. Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure. Congest Heart Fail. 2002; 8: 132–140.[Medline] [Order article via Infotrieve]
35. Umemura S, Nyui N, Tamura K, Hibi K, Yamaguchi S, Nakamaru M, Ishigami T, Yabana M, Kihara M, Inoue S, Ishii M. Plasma angiotensinogen concentrations in obese patients. Am J Hypertens. 1997; 10: 629–633.[CrossRef][Medline] [Order article via Infotrieve]
36. MacMahon SW, Wilcken DE, Macdonald GJ. The effect of weight reduction on left ventricular mass: a randomized controlled trial in young, overweight hypertensive patients. N Engl J Med. 1986; 314: 334–339.[Abstract]
37. Schulman SP, Weiss JL, Becker LC, Gottlieb SO, Woodruff KM, Weisfeldt ML, Gerstenblith G. The effects of antihypertensive therapy on left ventricular mass in elderly patients. N Engl J Med. 1990; 322: 1350–1356.[Abstract]
38. Mayet J, Shahi M, Foale RA, Poulter NR, Sever PS, McG Thom SA. Racial differences in cardiac structure and function in essential hypertension. BMJ. 1994; 308: 1011–1014.
39. Kizer JR, Arnett DK, Bella JN, Paranicas M, Rao DC, Province MA, Oberman A, Kitzman DW, Hopkins PN, Liu JE, Devereux RB. Differences in left ventricular structure between black and white hypertensive adults: the Hypertension Genetic Epidemiology Network study. Hypertension. 2004; 43: 1182–1188.
40. Voors AW, Foster TA, Frerichs RR, Webber LS, Berenson GS. Studies of blood pressures in children, ages 5–14 years, in a total biracial community: the Bogalusa Heart Study. Circulation. 1976; 54: 319–327.
41. Harshfield GA, Treiber FA, Wilson ME, Kapuku GK, Davis HC. A longitudinal study of ethnic differences in ambulatory blood pressure patterns in youth. Am J Hypertens. 2002; 15: 525–530.[CrossRef][Medline] [Order article via Infotrieve]
42. Hinderliter AL, Blumenthal JA, Waugh R, Chilukuri M, Sherwood A. Ethnic differences in left ventricular structure: relations to hemodynamics and diurnal blood pressure variation. Am J Hypertens. 2004; 17: 43–49.[CrossRef][Medline] [Order article via Infotrieve]
43. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA. 2004; 291: 2847–2850.
44. Muntner P, He J, Cutler JA, Wildman RP, Whelton PK. Trends in blood pressure among children and adolescents. JAMA. 2004; 291: 2107–2013.
45. Bronfin DR, Urbina EM. The role of the pediatrician in the promotion of cardiovascular health. Am J Med Sci. 1995; 310 (suppl 1): S42–S47.[CrossRef][Medline] [Order article via Infotrieve]
Related Article:
Circulation 2004 110: 3399.
This article has been cited by other articles:
 |
|
 |
|
  J P H Shield, E Crowne, and J Morgan Is there a place for bariatric surgery in treating childhood obesity? Arch. Dis. Child., May 1, 2008; 93(5): 369 - 372. [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Nesto and K. Mackie Endocannabinoid system and its implications for obesity and cardiometabolic risk Eur. Heart J. Suppl., March 1, 2008; 10(suppl_B): B34 - B41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. LaFontaine Physical Activity: The Epidemic of Obesity and Overweight Among Youth: Trends, Consequences, and Interventions American Journal of Lifestyle Medicine, February 1, 2008; 2(1): 30 - 36. [Abstract] [PDF]
|
|
|
|
 |
|
 F. Mzayek, S. Hassig, R. Sherwin, J. Hughes, W. Chen, S. Srinivasan, and G. Berenson The Association of Birth Weight with Developmental Trends in Blood Pressure from Childhood through Mid-Adulthood: The Bogalusa Heart Study Am. J. Epidemiol., August 15, 2007; 166(4): 413 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Hadtstein and F. Schaefer What adult nephrologists should know about childhood blood pressure Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2119 - 2123. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Avelar, T. V. Cloward, J. M. Walker, R. J. Farney, M. Strong, R. C. Pendleton, N. Segerson, T. D. Adams, R. E. Gress, S. C. Hunt, et al. Left Ventricular Hypertrophy in Severe Obesity: Interactions Among Blood Pressure, Nocturnal Hypoxemia, and Body Mass Hypertension, January 1, 2007; 49(1): 34 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Chinali, G. de Simone, M. J. Roman, E. T. Lee, L. G. Best, B. V. Howard, and R. B. Devereux Impact of Obesity on Cardiac Geometry and Function in a Population of Adolescents: The Strong Heart Study J. Am. Coll. Cardiol., June 6, 2006; 47(11): 2267 - 2273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. von Haehling, W. Doehner, and S. D. Anker Obesity and the Heart: A Weighty Issue J. Am. Coll. Cardiol., June 6, 2006; 47(11): 2274 - 2276. [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Matteucci, E. Wuhl, S. Picca, A. Mastrostefano, G. Rinelli, C. Romano, G. Rizzoni, O. Mehls, G. de Simone, F. Schaefer, et al. Left Ventricular Geometry in Children with Mild to Moderate Chronic Renal Insufficiency J. Am. Soc. Nephrol., January 1, 2006; 17(1): 218 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Childhood Adiposity Predicts Adult Hypertrophy DOC News, February 1, 2005; 2(2): 22 - 22. [Full Text]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||